Literature DB >> 7583614

Pulmonary haemodynamics after surfactant replacement in severe neonatal respiratory distress syndrome.

M C Bloom1, M Roques-Gineste, F Fries, M C Lelong-Tissier.   

Abstract

Aortopulmonary pressure difference and pulmonary blood flow velocity were studied during the first 48 hours of life in 12 premature neonates with severe respiratory distress syndrome (RDS), treated by natural surfactant, and in 25 premature neonates with mild RDS. A non-invasive Doppler ultrasound method was used to estimate aortopulmonary pressure difference and pulmonary blood flow velocity from the left pulmonary artery. Aortopulmonary pressure difference was significantly lower at 6 hours of age in the infants with severe RDS and was not increased one hour after surfactant therapy. Aortopulmonary gradient started to rise at 24 hours of age and was equal to that of neonates with mild RDS at 48 hours. Pulmonary blood flow velocity was significantly lower, initially in the severe RDS group, and was not increased one hour after surfactant therapy. Left pulmonary artery flow velocity began to rise after 24 hours and reached the values of the mild RDS group at 48 hours. These data indicate that aortopulmonary pressure difference and pulmonary blood flow are low in the acute phase of RDS and that surfactant treatment does not seem to affect these values.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583614      PMCID: PMC2528489          DOI: 10.1136/fn.73.2.f95

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  16 in total

1.  Postnatal circulatory adaptation in healthy term and preterm neonates.

Authors:  N J Evans; L N Archer
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

2.  Respiratory distress syndrome: echocardiographic assessment of cardiovascular function and pulmonary vascular resistance.

Authors:  H Halliday; S Hirschfeld; T Riggs; J Liebman; A Fanaroff; C Bormuth
Journal:  Pediatrics       Date:  1977-10       Impact factor: 7.124

3.  Doppler flow characteristics in the assessment of pulmonary artery pressure in ductus arteriosus.

Authors:  A B Houston; M K Lim; W B Doig; J Gnanapragasam; E N Coleman; M P Jamieson; J C Pollock
Journal:  Br Heart J       Date:  1989-10

4.  Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states.

Authors:  N N Musewe; J F Smallhorn; L N Benson; P E Burrows; R M Freedom
Journal:  Circulation       Date:  1987-11       Impact factor: 29.690

5.  Noninvasive Doppler echocardiographic evaluation of shunt flow dynamics of the ductus arteriosus.

Authors:  S Hiraishi; Y Horiguchi; H Misawa; K Oguchi; N Kadoi; N Fujino; K Yashiro
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

6.  Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease.

Authors:  T N Raju; D Vidyasagar; R Bhat; D Sobel; K M McCulloch; M Anderson; H Maeta; P S Levy; S Furner
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

7.  Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome.

Authors:  M P Seppänen; P O Kääpä; P O Kero; M Saraste
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

8.  Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.

Authors:  D Vidyasagar; H Maeta; T N Raju; E John; R Bhat; M Go; U Dahiya; Y Roberson; A Yamin; A Narula
Journal:  Pediatrics       Date:  1985-06       Impact factor: 7.124

9.  A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.

Authors:  J D Horbar; R F Soll; J M Sutherland; U Kotagal; A G Philip; D L Kessler; G A Little; W H Edwards; D Vidyasagar; T N Raju
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

10.  Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.

Authors:  M Hallman; T A Merritt; A L Jarvenpaa; B Boynton; F Mannino; L Gluck; T Moore; D Edwards
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

View more
  2 in total

1.  The effects of surfactant on haemodynamics in hyaline membrane disease.

Authors:  J Skinner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

Review 2.  Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.

Authors:  Nashwa El-Gendy; Anubhav Kaviratna; Cory Berkland; Prajnaparamita Dhar
Journal:  Ther Deliv       Date:  2013-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.